La Rosa Abel De serves as Executive at Virios Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, La Rosa Abel De has executed 1 insider transactions totaling $23.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 7, 2022 involved purchasing 4,000 shares valued at $23.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 7, 2022 | VIRI | $23.6K | Purchase | 4,000 | $5.90 | Discretionary |
La Rosa Abel De currently holds 4,000 shares of Virios Therapeutics, Inc. (VIRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, La Rosa Abel De has been a net buyer of VIRI stock. They have purchased $23.6K and sold $0 worth of shares.
La Rosa Abel De's most recent insider trade was on Jan 7, 2022, when they purchased 4,000 shares at $5.90 per share.
Get notified when new Form 4 filings are submitted